Discontinuation of Low-Profit, Difficult-to-Improve Dental Microscopes and Other Products
First written in FY2020-Q1. 1 of 3 entries say "Advanced", first in FY2020-Q2. Latest entry: FY2020-Q3.
1 other company's latest entry also says "Restated".
- FY2020-Q3RestatedAnnual report
「Revenue was ¥4,601 million, down 12.5% year on year, due to sluggish sales of reamers and files as clinics, mainly in Asia and Europe, were closed for a certain period because of the impact of the novel coronavirus disease (COVID-19), as well as a decline in revenue resulting from the discontinuation of sales of dental operating microscopes and other products.」
The disclosure states that the decline in revenue resulting from the discontinuation of sales of dental operating microscopes and other products continues to be reflected in performance. - FY2020-Q2AdvancedAnnual report
「Operating profit benefited from an improvement in the gross profit margin resulting from the discontinuation of sales of dental operating microscopes and other products, while」
The discontinuation of sales of dental operating microscopes and other products with a limited contribution to earnings and limited scope for quality improvement was reflected in performance as an improvement in the gross profit margin. - FY2020-Q1First statedAnnual report
「Sales declined following the discontinuation of sales of dental operating microscopes and other products that made a limited contribution to earnings and whose quality was difficult for the company to improve independently.」
The disclosure states that sales of products making a limited contribution to earnings and whose quality was difficult to improve independently were discontinued.